This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Piracetam
Piracetam is the original racetam and the compound that coined the term "nootropic." It modulates neurotransmitter systems and improves cerebral blood flow to support memory, learning, and cognitive clarity - particularly in ageing or impaired populations.
Benefits
What is Piracetam?
Piracetam (2-oxo-1-pyrrolidine acetamide) was synthesised in 1964 by Romanian psychologist and chemist Dr Corneliu Giurgea, who also coined the term "nootropic" (from the Greek noos meaning mind, and tropein meaning to bend or turn). It was the first compound specifically developed and categorised as a cognitive enhancer, and remains the most studied member of the racetam family.
Piracetam has been widely prescribed in Europe and parts of Asia for decades, primarily for age-related cognitive decline, dyslexia, and vertigo. While its effects in healthy young adults are generally subtle, it has a strong track record of improving memory, verbal fluency, and learning capacity in elderly and cognitively impaired individuals.
Despite its long history and extensive research, piracetam's precise mechanism of action remains only partially understood. It does not act as a sedative or stimulant and has an exceptionally safe toxicity profile, which was one of Giurgea's original criteria for a true nootropic.
- Acetylcholine modulation: Piracetam enhances cholinergic neurotransmission by increasing the density and sensitivity of acetylcholine receptors, supporting memory formation and recall.
- Membrane fluidity: It improves the fluidity and integrity of neuronal cell membranes, which tends to decline with age, supporting efficient signal transduction between neurons.
- Cerebral blood flow: Piracetam increases blood flow to the brain and improves oxygen utilisation, enhancing overall cerebral metabolism.
- Glutamate modulation: It positively modulates AMPA and NMDA glutamate receptors, which are critical for synaptic plasticity, learning, and long-term potentiation.
- Neuroprotection: Offers protection against hypoxia (low oxygen) and oxidative stress, helping to preserve cognitive function under adverse conditions.
- Typical dose: 1,200–4,800 mg per day, divided into 2–3 doses
- Common starting dose: 1,600 mg three times daily (4,800 mg total)
- Attack dose: Some users begin with a higher "attack dose" of 4,800–9,600 mg for the first few days, then reduce to maintenance
- Onset: Effects may take 1–2 weeks of consistent use to become noticeable
- With choline: Often stacked with a choline source (Alpha-GPC or citicoline) to prevent headaches and enhance effects
Piracetam is water-soluble and can be taken with or without food. It has a slightly bitter taste in powder form.
- Side effects: Very mild - occasional headache (often due to choline depletion), insomnia, anxiety, or gastrointestinal discomfort.
- Toxicity: Extremely low. The LD50 in animal studies is remarkably high, and no deaths have been attributed to piracetam overdose in humans.
- Drug interactions: May enhance the effects of blood thinners (anticoagulants). Consult a doctor if taking warfarin or similar medications.
- Pregnancy: Not recommended due to insufficient data.
- Legal status: Prescription medication in some European countries. Not approved by the FDA as a drug or dietary supplement in the US. Unregulated in the UK.
Natural Sources & Forms
- Synthetic compound: Piracetam does not occur in nature - it must be synthesised
- Supplement form: Available as capsules, tablets, and bulk powder from nootropic vendors
- Brand names: Nootropil (prescription), various generic formulations
- Related racetams: Aniracetam, oxiracetam, and phenylpiracetam are structurally related compounds with different potency profiles
Research Studies
Frequently Asked Questions
Piracetam is the original racetam and the compound that coined the term "nootropic." It modulates neurotransmitter systems and improves cerebral blood flow to support memory, learning, and cognitive clarity - particularly in ageing or impaired populations.
The key benefits of Piracetam include: Cognitive Enhancement, Creativity, Focus, Longevity, Memory, Mood.
Acetylcholine modulation: Piracetam enhances cholinergic neurotransmission by increasing the density and sensitivity of acetylcholine receptors, supporting memory formation and recall. Membrane fluidity: It improves the fluidity and integrity of neuronal cell membranes, which tends to decline with age, supporting efficient signal transduction between neurons. Cerebral blood flow: Piracetam increases blood flow to the brain and improves oxygen utilisation, enhancing overall cerebral metabolism. Glutamate modulation: It positively modulates AMPA and NMDA glutamate receptors, which are critical for synaptic plasticity, learning, and long-term potentiation. Neuroprotection: Offers protection against hypoxia (low oxygen) and oxidative stress, helping to preserve cognitive function under adverse conditions.
Typical dose: 1,200–4,800 mg per day, divided into 2–3 doses Common starting dose: 1,600 mg three times daily (4,800 mg total) Attack dose: Some users begin with a higher "attack dose" of 4,800–9,600 mg for the first few days, then reduce to maintenance Onset: Effects may take 1–2 weeks of consistent use to become noticeable With choline: Often stacked with a choline source (Alpha-GPC or citicoline) to prevent headaches and enhance effects Piracetam is water-soluble and can be taken with or without food. It has a slightly bitter taste in powder form.
Side effects: Very mild - occasional headache (often due to choline depletion), insomnia, anxiety, or gastrointestinal discomfort. Toxicity: Extremely low. The LD50 in animal studies is remarkably high, and no deaths have been attributed to piracetam overdose in humans. Drug interactions: May enhance the effects of blood thinners (anticoagulants). Consult a doctor if taking warfarin or similar medications. Pregnancy: Not recommended due to insufficient data. Legal status: Prescription medication in some European countries. Not approved by the FDA as a drug or dietary supplement in the US. Unregulated in the UK.
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!